Sanjivani Paranteral Limited

₹184.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:531569Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 22.72%
Div yield —
ROE 19.03%
Pharmaceutical Preparations
Beta (5Y) 0.01
PE TTM 22.31
TSR TTM (12.69%)
Mkt cap ₹2.260B
ROIC 14.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹204
10.76%
270.29%
Hold 0|11|6|8|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.20
3.58
3.87
4.18
23.85%
28.41%
27.51%
36.26%
Revenue₹M
139.3
135.7
139.9
137.4
1.27%
(4.90%)
(0.82%)
(2.23%)
Peers (US$23.12M)
Cap (US$)
PE
23.28M
12.14x
Capital
TTM
5Y
10Y
Leveragex
0.617
1.346
1.199
EBIT/Intx
0.569
0.050
0.054
Own earn%
(128.39)
27.05
37.72
Sh yield%
44.20
46.79
47.27
Owners
Insiders/Inst%
12.28
36.60
Short interest%
0.69
SBC / revenue%
2.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
7–15
$1 testx
—
Incr. ROIC%
1